암센터 국문 논문 목록
책임저자
제1저자 |
저자,논문명,학술지명,발간일;년도;페이지:통권(Impact Factor) |
공선영
(표적치료연구과)
우상명
(종양면역연구과)
|
공선영, 우상명:전중원:이동은, 김윤희, 한성식, 박상재, 이우진. Optimal Value of Mutant KRAS Circulating Tumor DNA for Predicting Prognosis and Monitoring in Patients with Pancreatic Adenocarcinoma: A Prospective Multicenter Cohort Study
CLINICAL CHEMISTRY. 2025-06-13; 2025;
71(9):993~1004.
IF 6.3 (2024)
|
전중원
(중재의학연구과)
|
임명철
(희귀난치암연구부)
|
임명철:배재경:이동운, 유기호, 이동은, 김지현, Robert Armbrust, 박상윤, Christina Fotopoulou. Surgical outcomes of rectosigmoid colon resection versus rectosigmoid wall stripping for superficial rectal wall tumors at cytoreductions for advanced ovarian cancer
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER. 2025-06-13; 2025;
35(8):101973~.
IF 4.7 (2024)
|
배재경
(산부인과)
|
이영주
(표적치료연구과)
|
이영주:최유라:황미화, 김재민, 박석연, 김선신. Overcoming MET-targeted drug resistance in MET-amplified lung cancer by aurora kinase B inhibition
BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH. 2025-06-09; 2025;
1872(7):120001~.
IF 3.7 (2024)
|
최유라
(표적치료연구과)
|
Gi Jeong Cheon, Young Joo Park
|
Gi Jeong Cheon, Young Joo Park:장진선, Hyun Joo Kim:. Comparison of Ultrasensitive and Highly Sensitive Assay to Predict Stimulated Thyroglobulin Levels Using Unstimulated Levels in Differentiated Thyroid Cancer Patients
ENDOCRINOLOGY AND METABOLISM. 2025-06-05; 2025;
:~.
IF 4.2 (2024)
|
장진선
(내분비내과분과)
|
임명철
(희귀난치암연구부)
|
임명철:배재경:Eun Young Park, 김의숙, 김준환, 김지현, 전준영, 최영주. Impact of Clostridium difficile Infection on Chemotherapy in Patients With Primary Ovarian Cancer
JOURNAL OF KOREAN MEDICAL SCIENCE. 2025-06-04; 2025;
40:e179~.
IF 2.3 (2024)
|
배재경
(산부인과)
|
이인준
(중재의학연구과)
|
이인준:이인준:Hyo-Cheol Kim. Optimizing Yttrium-90 Radioembolization Dosimetry for Hepatocellular Carcinoma: A Korean Perspective
KOREAN JOURNAL OF RADIOLOGY. 2025-06-04; 2025;
26(7):688~703.
IF 5.3 (2024)
|
이인준
(중재의학연구과)
|
김영애
(암관리정책부)
|
김영애:Su Jung Lee:장솔비, 홍용은, Hyun Suk Park. Experience of participating in national home-based medical care project for cancer patients with a temporary stoma: a qualitative study
SUPPORTIVE CARE IN CANCER. 2025-06-02; 2025;
33(6):525~.
IF 3 (2024)
|
Su Jung Lee
|
최귀선
(보건AI학과)
|
최귀선:하예진:Xuan Quy Luu, 김우림, 전재관, 서민아. Socioeconomic inequality in organized and opportunistic screening for breast cancer: results from the Korean National Cancer Screening Survey, 2009-2021
EPIDEMIOLOGY AND HEALTH. 2025-05-30; 2025;
47:e2025031~.
IF 2.2 (2024)
|
하예진
(암예방사업부)
|
정재영
(표적치료연구과)
|
정재영, Whi-An Kwon:Whi-An Kwon:. T-Cell Engager Therapy in Prostate Cancer: Molecular Insights into a New Frontier in Immunotherapy
CANCERS. 2025-05-29; 2025;
17(11):1820~.
IF 4.4 (2024)
|
Whi-An Kwon
|
임명철
(산부인과)
|
임명철:김지현:. Letter re: Benefit from maintenance with PARP inhibitor in newly diagnosed ovarian cancer according to BRCA1/2 mutation type and site: a multicenter real-world study: Ethnic difference in BRCT domain response to PARP inhibitor
ESMO OPEN. 2025-05-27; 2025;
10(6):105288~.
IF 8.3 (2024)
|
김지현
(산부인과)
|
